Ginkgo Bioworks Holdings Inc vs Vanguard S&P 500 ETF — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.58 (market cap $505.73M), while Vanguard S&P 500 ETF trades at $711.31. The key difference: Vanguard S&P 500 ETF is trading nearer its 52-week high, Ginkgo Bioworks Holdings Inc nearer its low. Which is the better fit depends on your goals.
| DNA | VOO | |
|---|---|---|
Market Cap | $505.73M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $16.14 | $710.71 |
52-Week Low | $5.48 | $580.93 |
Enterprise Value | $607.68M | — |
Trailing returns across standard periods
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →VOO is a foundational ETF that tracks the S&P 500 Index, providing exposure to 500 of the largest and most established companies in the United States. Renowned for its ultra-low expense ratio and tax efficiency, it serves as a core building block for long-term investors seeking to capture the total return of the U.S. large-cap market in a single, highly liquid vehicle.
Read more on VOO →